Annual Revenue
$1.06 M
+$1.29 M+568.72%
March 31, 2024
Summary
- As of February 23, 2025, VTGN annual revenue is $1.06 million, with the most recent change of +$1.29 million (+568.72%) on March 31, 2024.
- During the last 3 years, VTGN annual revenue has fallen by -$25.50 thousand (-2.34%).
- VTGN annual revenue is now -20.73% below its all-time high of $1.34 million, reached on March 31, 2012.
Performance
VTGN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$234.00 K
+$51.00 K+27.87%
December 31, 2024
Summary
- As of February 23, 2025, VTGN quarterly revenue is $234.00 thousand, with the most recent change of +$51.00 thousand (+27.87%) on December 31, 2024.
- Over the past year, VTGN quarterly revenue has increased by +$150.00 thousand (+178.57%).
- VTGN quarterly revenue is now -81.28% below its all-time high of $1.25 million, reached on December 31, 2016.
Performance
VTGN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$698.00 K
-$177.00 K-20.23%
December 31, 2024
Summary
- As of February 23, 2025, VTGN TTM revenue is $698.00 thousand, with the most recent change of -$177.00 thousand (-20.23%) on December 31, 2024.
- Over the past year, VTGN TTM revenue has dropped by -$272.00 thousand (-28.04%).
- VTGN TTM revenue is now -53.83% below its all-time high of $1.51 million, reached on December 31, 2021.
Performance
VTGN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VTGN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +568.7% | +178.6% | -28.0% |
| 3 y3 years | -2.3% | +178.6% | -28.0% |
| 5 y5 years | - | +178.6% | -28.0% |
VTGN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | +568.7% | -43.1% | +126.2% | -53.8% | +291.8% |
| 5 y | 5-year | -4.0% | +568.7% | -47.0% | +126.2% | -53.8% | +291.8% |
| alltime | all time | -20.7% | +568.7% | -81.3% | +126.2% | -53.8% | +291.8% |
VistaGen Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $234.00 K(+27.9%) | $698.00 K(-20.2%) |
| Sep 2024 | - | $183.00 K(+117.9%) | $875.00 K(-9.8%) |
| Jun 2024 | - | $84.00 K(-57.4%) | $970.00 K(-8.7%) |
| Mar 2024 | $1.06 M(-568.7%) | $197.00 K(-52.1%) | $1.06 M(+2.0%) |
| Dec 2023 | - | $411.00 K(+47.8%) | $1.04 M(+28.6%) |
| Sep 2023 | - | $278.00 K(+57.1%) | $810.50 K(-325.1%) |
| Jun 2023 | - | $177.00 K(+0.6%) | -$360.00 K(+58.7%) |
| Mar 2023 | -$227.00 K(-120.5%) | $175.90 K(-2.1%) | -$226.90 K(-37.6%) |
| Dec 2022 | - | $179.60 K(-120.1%) | -$363.90 K(+96.1%) |
| Sep 2022 | - | -$892.50 K(-387.8%) | -$185.60 K(-117.4%) |
| Jun 2022 | - | $310.10 K(+697.2%) | $1.06 M(-4.0%) |
| Mar 2022 | $1.11 M | $38.90 K(-89.1%) | $1.11 M(-26.7%) |
| Dec 2021 | - | $357.90 K(-0.0%) | $1.51 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $358.00 K(+1.1%) | $1.47 M(+1.7%) |
| Jun 2021 | - | $354.10 K(-19.9%) | $1.44 M(+32.5%) |
| Mar 2021 | $1.09 M(-12.8%) | $441.90 K(+40.9%) | $1.09 M(+68.2%) |
| Dec 2020 | - | $313.60 K(-6.1%) | $647.60 K(+93.9%) |
| Sep 2020 | - | $334.00 K(-73.3%) | $334.00 K(-73.3%) |
| Mar 2017 | $1.25 M(+523.8%) | - | - |
| Dec 2016 | - | $1.25 M(+523.8%) | $1.25 M(+26.5%) |
| Mar 2013 | $200.40 K(-85.1%) | - | - |
| Jun 2012 | - | $200.40 K(-57.3%) | $988.00 K(-26.4%) |
| Mar 2012 | $1.34 M | $468.90 K(>+9900.0%) | $1.34 M(+53.7%) |
| Dec 2011 | - | $2400.00(-99.2%) | $873.30 K(+0.3%) |
| Sep 2011 | - | $316.30 K(-43.0%) | $870.90 K(+57.0%) |
| Jun 2011 | - | $554.60 K | $554.60 K |
FAQ
- What is VistaGen Therapeutics annual revenue?
- What is the all time high annual revenue for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual revenue year-on-year change?
- What is VistaGen Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly revenue year-on-year change?
- What is VistaGen Therapeutics TTM revenue?
- What is the all time high TTM revenue for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM revenue year-on-year change?
What is VistaGen Therapeutics annual revenue?
The current annual revenue of VTGN is $1.06 M
What is the all time high annual revenue for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual revenue is $1.34 M
What is VistaGen Therapeutics annual revenue year-on-year change?
Over the past year, VTGN annual revenue has changed by +$1.29 M (+568.72%)
What is VistaGen Therapeutics quarterly revenue?
The current quarterly revenue of VTGN is $234.00 K
What is the all time high quarterly revenue for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly revenue is $1.25 M
What is VistaGen Therapeutics quarterly revenue year-on-year change?
Over the past year, VTGN quarterly revenue has changed by +$150.00 K (+178.57%)
What is VistaGen Therapeutics TTM revenue?
The current TTM revenue of VTGN is $698.00 K
What is the all time high TTM revenue for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM revenue is $1.51 M
What is VistaGen Therapeutics TTM revenue year-on-year change?
Over the past year, VTGN TTM revenue has changed by -$272.00 K (-28.04%)